Home Business

IDBI follow-on offer in January

IDBI Bank said on Friday it would come out with a follow-on public offer (FPO) in January to meet its capital needs. It also plans to raise $500 million through overseas bonds to fund Indian corporates’ expansion programmes abroad. - IDBI Bank FPO likely in January - Govt mulls PSU disinvestment piggyriding on FPOs - IDBI Bank raises $225 million loan - IDBI Bank net surges 56% to Rs 254 cr - SAIL stake sale in FY10: Steel minister - Govt asks IDBI to review mortgage arm sale decision Asked about the amount it plans to raise, CMD Yogesh Agarwal said, “The size of the issue will be double of what the government is willing to subscribe.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
M&M erases gains, ends down 1%
The stock erased all its gains and slipped into the negative terrain to touch a low of Rs 1,005. The stock finally ended at at Rs 1010, down 1% from its previous close. The counter clocked volumes of 136,077 shares as compared to the two-week daily average traded volumes of 147,279 shares on the BSE.
Popular Articles

V V: Berlin Wall, 1989 and after
All successful publishers and authors have an impeccable sense of timing and generate literature with an eye upon the calendar. So it isn’t surprising that we have a flood of books on the fall of the Berlin Wall that started the process of disintegration of the Soviet Union and the collapse of communism in Europe. But what we have is an embarrassment of riches which try to unravel why such an all-embracing system that Alexander Solzhenitsyn described as “all pervasive, paranoid, oppressive, incompetent, lethal” in the latest edition of The First Circle (Harper, $18), came to an unexpected end. Almost everyone had expected that it would have to be killed; instead it collapsed, as if a house had fallen in on itself. What happened?

LifeCell plans to set up facilities in West Asia
LifeCell International, a stem cell banking services provider, is in the process of raising $10 million from a private equity fund. The firm wants to raise the money for financing clinical trials and for setting up storage facilities for the harvested stem cells.